Literature DB >> 20161679

Dengue virus markers of virulence and pathogenicity.

Rebeca Rico-Hesse1.   

Abstract

The increased spread of dengue fever and its more severe form, dengue hemorrhagic fever, have made the study of the mosquito-borne dengue viruses that cause these diseases a public health priority. Little is known about how or why the four different (serotypes 1-4) dengue viruses cause pathology in humans only, and there have been no animal models of disease to date. Therefore, there are no vaccines or antivirals to prevent or treat infection and mortality rates of dengue hemorrhagic fever patients can reach up to 20%. Cases occur mainly in tropical zones within developing countries worldwide, and control measures have been limited to the elimination of the mosquito vectors. Thus, it is imperative that we develop new methods of studying dengue virus pathogenicity. This article presents new approaches that may help us to understand dengue virus virulence and the specific mechanisms that lead to dengue fever and severe disease.

Entities:  

Year:  2009        PMID: 20161679      PMCID: PMC2821058          DOI: 10.2217/fvl.09.51

Source DB:  PubMed          Journal:  Future Virol        ISSN: 1746-0794            Impact factor:   1.831


  67 in total

Review 1.  Dengue.

Authors:  Scott B Halstead
Journal:  Lancet       Date:  2007-11-10       Impact factor: 79.321

2.  Comparison of plaque- and flow cytometry-based methods for measuring dengue virus neutralization.

Authors:  Annette A Kraus; William Messer; Laura B Haymore; Aravinda M de Silva
Journal:  J Clin Microbiol       Date:  2007-09-05       Impact factor: 5.948

3.  Phylogeny of the genus Flavivirus.

Authors:  G Kuno; G J Chang; K R Tsuchiya; N Karabatsos; C B Cropp
Journal:  J Virol       Date:  1998-01       Impact factor: 5.103

4.  Molecular and in vitro analysis of eight dengue type 2 viruses isolated from patients exhibiting different disease severities.

Authors:  M N Mangada; A Igarashi
Journal:  Virology       Date:  1998-05-10       Impact factor: 3.616

5.  Epidemiologic, clinical, and virologic observations on dengue in the Kingdom of Tonga.

Authors:  D J Gubler; D Reed; L Rosen; J R Hitchcock
Journal:  Am J Trop Med Hyg       Date:  1978-05       Impact factor: 2.345

6.  Dengue fever in humanized NOD/SCID mice.

Authors:  Dennis A Bente; Michael W Melkus; J Victor Garcia; Rebeca Rico-Hesse
Journal:  J Virol       Date:  2005-11       Impact factor: 5.103

7.  Supernatants from dengue virus type-2 infected macrophages induce permeability changes in endothelial cell monolayers.

Authors:  Jillian M Carr; Helen Hocking; Karen Bunting; Peter J Wright; Andrew Davidson; Jennifer Gamble; Christopher J Burrell; Peng Li
Journal:  J Med Virol       Date:  2003-04       Impact factor: 2.327

8.  Effect of dengue-1 antibodies on American dengue-2 viral infection and dengue haemorrhagic fever.

Authors:  Tadeusz J Kochel; Douglas M Watts; Scott B Halstead; Curtis G Hayes; Angelica Espinoza; Vidal Felices; Roxana Caceda; Christian T Bautista; Ysabel Montoya; Susan Douglas; Kevin L Russell
Journal:  Lancet       Date:  2002-07-27       Impact factor: 79.321

9.  Models of dengue virus infection.

Authors:  Dennis A Bente; Rebeca Rico-Hesse
Journal:  Drug Discov Today Dis Models       Date:  2006

10.  Severe dengue epidemics in Sri Lanka, 2003-2006.

Authors:  Nalaka Kanakaratne; Wahala M P B Wahala; William B Messer; Hasitha A Tissera; Aruna Shahani; Nihal Abeysinghe; Aravinda M de-Silva; Maya Gunasekera
Journal:  Emerg Infect Dis       Date:  2009-02       Impact factor: 6.883

View more
  11 in total

Review 1.  Patterns, Drivers, and Challenges of Vector-Borne Disease Emergence.

Authors:  Andrea Swei; Lisa I Couper; Lark L Coffey; Durrell Kapan; Shannon Bennett
Journal:  Vector Borne Zoonotic Dis       Date:  2019-12-03       Impact factor: 2.133

Review 2.  Factors shaping the adaptive landscape for arboviruses: implications for the emergence of disease.

Authors:  Lark L Coffey; Naomi Forrester; Konstantin Tsetsarkin; Nikos Vasilakis; Scott C Weaver
Journal:  Future Microbiol       Date:  2013-02       Impact factor: 3.165

3.  The importance of hematopoietic progenitor cells in dengue.

Authors:  Jih-Jin Tsai; Li-Teh Liu; Ko Chang; Shu-Hui Wang; Hui-Mien Hsiao; Kristina B Clark; Guey Chuen Perng
Journal:  Ther Adv Hematol       Date:  2012-02

4.  Analysis of dengue infection based on Raman spectroscopy and support vector machine (SVM).

Authors:  Saranjam Khan; Rahat Ullah; Asifullah Khan; Noorul Wahab; Muhammad Bilal; Mushtaq Ahmed
Journal:  Biomed Opt Express       Date:  2016-05-18       Impact factor: 3.732

5.  Issues related to recent dengue vaccine development.

Authors:  Eiji Konishi
Journal:  Trop Med Health       Date:  2011-08-06

6.  Transient Monocytosis Subjugates Low Platelet Count in Adult Dengue Patients.

Authors:  Jih-Jin Tsai; Jung-San Chang; Ko Chang; Po-Chih Chen; Li-Teh Liu; Tzu-Chuan Ho; Sia Seng Tan; Yu-Wen Chien; Yu-Chih Lo; Guey Chuen Perng
Journal:  Biomed Hub       Date:  2017-03-03

7.  Immunologic hypo- or non-responder in natural dengue virus infection.

Authors:  Guey Chuen Perng; Kulkanya Chokephaibulkit
Journal:  J Biomed Sci       Date:  2013-05-31       Impact factor: 8.410

Review 8.  Role of cognitive parameters in dengue hemorrhagic fever and dengue shock syndrome.

Authors:  Jih-Jin Tsai; Kulkanya Chokephaibulkit; Po-Chih Chen; Li-Teh Liu; Hui-Mien Hsiao; Yu-Chih Lo; Guey Chuen Perng
Journal:  J Biomed Sci       Date:  2013-12-05       Impact factor: 8.410

9.  Time to Harmonize Dengue Nomenclature and Classification.

Authors:  Lize Cuypers; Pieter J K Libin; Peter Simmonds; Ann Nowé; Jorge Muñoz-Jordán; Luiz Carlos Junior Alcantara; Anne-Mieke Vandamme; Gilberto A Santiago; Kristof Theys
Journal:  Viruses       Date:  2018-10-18       Impact factor: 5.048

10.  Expression of Nitric Oxide Synthase and Nitric Oxide Levels in Peripheral Blood Cells and Oxidized Low-Density Lipoprotein Levels in Saliva as Early Markers of Severe Dengue.

Authors:  Harsha Hapugaswatta; Ruwani L Wimalasekara; Suharshi S Perera; Ranjan Premaratna; Kapila N Seneviratne; Nimanthi Jayathilaka
Journal:  Biomed Res Int       Date:  2021-02-09       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.